+47.4%
NSC vs THC
+250.3%
-202.9%
-35.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.6% | -0.1% | +0.4% |
| 7D | -5.5% | -0.7% | -4.9% | -5.4% |
| 30D | -3.2% | +1.3% | -4.5% | -3.5% |
| 3M | +7.7% | +64.2% | -56.6% | -1.6% |
| 6M | +4.5% | +8.3% | -3.8% | +2.4% |
| YTD | +15.6% | +33.4% | -17.8% | +8.8% |
| 1Y | +19.8% | +37.7% | -17.8% | +11.7% |
| 3Y | +70.1% | +236.8% | -166.7% | +28.4% |
| All | +47.4% | +250.3% | -202.9% | +7.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling